Molecular Imaging

Molecular imaging (also called nuclear medicine or nuclear imaging) can image the function of cells inside the body at the molecular level. This includes the imaging modalities of positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. How does PET and SPECT imaging work? Small amounts of radioactive material (radiopharmaceuticals) injected into a patient. These can use sugars or chemical traits to bond to specific cells. The radioactive material is taken up by cells that consume the sugars. The radiation emitted from inside the body is detected by photon detectors outside the body. Computers take the data to assemble images of the radiation emissions. Nuclear images may appear fuzzy or ghostly rather than the sharper resolution from MRI and CT. But, it provides metabolic information at a cellular level, showing if there are defects in the function of the heart, areas of very high metabolic activity associated with cancer cells, or areas of inflammation, data not available from other modalities. These noninvasive imaging exams are used to diagnose cancer, heart disease, Alzheimer’s and Parkinson’s disease, bone disorders and other disorders.

New Mexico company sets sights on bolstering the domestic supply of Mo-99
Eden Radioisotopes believes the facility will have the capacity to produce up to 50% of the global demand for Mo-99 once completed.
Patients in rural communities struggle to access newer tumor-targeting radiotracers
In some cases, patients in isolated areas must travel up to 130 miles to gain access to the latest class of NETs, new data suggest.
Investigational radiotracer has 'extremely valuable' potential for treating chronic condition
New findings suggest that 99mTc-maraciclatide can help physicians more accurately identify endometriosis on imaging.
'Sterility failures' prompt FDA to threaten radiopharmaceutical producer with disciplinary action
Multiple issues that could raise the risk of product contamination were discovered during an inspection, according to an FDA warning letter.
Radiopharmaceutical manufacturer secures $30M to bolster domestic isotope production
Although the company is already bringing in revenue from medical radioisotopes, the new funding will help further these initiatives and drive additional research and development.

New Mexico company sets sights on bolstering the domestic supply of Mo-99

Eden Radioisotopes believes the facility will have the capacity to produce up to 50% of the global demand for Mo-99 once completed.

Patients in rural communities struggle to access newer tumor-targeting radiotracers

In some cases, patients in isolated areas must travel up to 130 miles to gain access to the latest class of NETs, new data suggest.

Endometriosis radiotracer performs well at clinical trial

Investigational radiotracer has 'extremely valuable' potential for treating chronic condition

New findings suggest that 99mTc-maraciclatide can help physicians more accurately identify endometriosis on imaging.

'Sterility failures' prompt FDA to threaten radiopharmaceutical producer with disciplinary action

Multiple issues that could raise the risk of product contamination were discovered during an inspection, according to an FDA warning letter.

Radiopharmaceutical manufacturer secures $30M to bolster domestic isotope production

Although the company is already bringing in revenue from medical radioisotopes, the new funding will help further these initiatives and drive additional research and development.

Department of Energy, Shine working on $263M deal to establish Mo-99 supply in US

If approved, the funds would go toward the completion of Chrysalis—Shine's first-of-its-kind medical isotope production facility.

mergers and acquisitions handshake deal business

Radiopharma firm secures $85M to expand domestic production of radioisotopes

SpectronRx announced the funding on April 2, highlighting the critical need for a reliable domestic supply of radiopharmaceuticals.

Department of energy partners to bolster domestic radioisotope supply

Gadolinium-153, or Gd-153, is routinely used to calibrate nuclear imaging equipment. It has been in short supply since 2023 when global distribution of the radioisotope came to a halt.